Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_assertion type Assertion NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_head.
- NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_assertion description "[Patients with transitional-cell carcinoma confirmed to the bladder that demonstrates nuclear p53 reactivity should be considered for protocols of adjuvant treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_provenance.
- NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_assertion evidence source_evidence_literature NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_provenance.
- NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_assertion SIO_000772 7935683 NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_provenance.
- NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_assertion wasDerivedFrom befree-2016 NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_provenance.
- NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_assertion wasGeneratedBy ECO_0000203 NP1327529.RAcJESP3Geb9kfVuvii43JTAKn0jt3fLxOaIJ8ddMT6xM130_provenance.